Viral Hepatitis and Therapeutic Strategies
A special issue of Pathogens (ISSN 2076-0817).
Deadline for manuscript submissions: 20 November 2025 | Viewed by 9
Special Issue Editor
Special Issue Information
Dear Colleagues,
Viral hepatitis is a major cause of liver disease worldwide. Numerous different strains of viruses can cause hepatitis, including hepatitis A, B, C, D, and E, where hepatitis A-C are the most common infections, while hepatitis D and E occur less frequently. The duration, severity, and treatment options for viral hepatitis particularly depend on the type of pathogen and associated comorbidities. Some individuals may promptly develop fulminant liver failure requiring urgent liver transplantation, while others slowly progress towards end-stage liver disease, including cirrhosis and hepatocellular carcinoma. Regardless of the significant advancement in the understanding of these infections, the mechanism of pathogenesis remains a complicated and scarcely defined process mediated by complex interactions between the host and the virus, making it difficult to achieve a functional cure. The comprehensive understanding of the host–pathogen interaction dynamics on molecular and cellular levels, the mechanisms of viral entry into the hepatocytes and their replication process, the evasion of the host immune response, and the initiation of hepatocellular damage and its subsequent progression towards end-stage liver disease is really warranted to develop novel and more effective therapeutic strategies to treat every individual, as the current approved treatment modalities show limited efficacy in complete and successful viral eradication. Hence, there is a critical need for newer molecules to achieve a functional cure.
Dr. Arshi Khanam
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- viral hepatitis
- acute and chronic infections
- viral pathogenesis and persistence
- therapeutic strategies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
